You are here

Will Zyprexa join Vioxx ?

Mostafa Hussein, Blogging on the wrong side - Mon, 29/10/2007 - 5:08pm

Lilly the manufacturer of the atypical antipsychotic Zyprexa(Olanzapine) and Symbiax(Olanzapine + Fluoxetine) will add a black box warning on its product regarding its metabolic side effects.

Olanzapine is an antipsychotic (AP) used mainly for the treatment of Schizophrenia and Bipolar disorder.

An atypical antipsychotic, is a newer class of antipsychotics that work in a different mechanism compared to older generation APs that causes minimal extrapyramidal side effects (EPS).

read more